PROCTER & GAMBLE HEALTH | DR. REDDYS LAB | PROCTER & GAMBLE HEALTH/ DR. REDDYS LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | 19.9 | 174.5% | View Chart |
P/BV | x | 10.6 | 4.5 | 236.5% | View Chart |
Dividend Yield | % | 2.0 | 0.6 | 311.2% |
PROCTER & GAMBLE HEALTH DR. REDDYS LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
DR. REDDYS LAB Mar-23 |
PROCTER & GAMBLE HEALTH/ DR. REDDYS LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 4,656 | 115.2% | |
Low | Rs | 3,883 | 3,788 | 102.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 1,481.4 | 50.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 270.7 | 51.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 345.7 | 44.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 40.00 | 237.5% | |
Avg Dividend yield | % | 2.1 | 0.9 | 216.8% | |
Book value per share (Unadj.) | Rs | 447.6 | 1,389.6 | 32.2% | |
Shares outstanding (eoy) | m | 16.60 | 166.53 | 10.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.8 | 219.1% | |
Avg P/E ratio | x | 33.5 | 15.6 | 214.5% | |
P/CF ratio (eoy) | x | 29.8 | 12.2 | 244.1% | |
Price / Book Value ratio | x | 10.3 | 3.0 | 340.0% | |
Dividend payout | % | 68.7 | 14.8 | 465.0% | |
Avg Mkt Cap | Rs m | 76,761 | 703,039 | 10.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 46,466 | 4.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 246,697 | 5.0% | |
Other income | Rs m | 184 | 10,555 | 1.7% | |
Total revenues | Rs m | 12,480 | 257,252 | 4.9% | |
Gross profit | Rs m | 3,247 | 63,860 | 5.1% | |
Depreciation | Rs m | 281 | 12,502 | 2.2% | |
Interest | Rs m | 8 | 1,428 | 0.5% | |
Profit before tax | Rs m | 3,142 | 60,485 | 5.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 15,412 | 5.5% | |
Profit after tax | Rs m | 2,295 | 45,073 | 5.1% | |
Gross profit margin | % | 26.4 | 25.9 | 102.0% | |
Effective tax rate | % | 27.0 | 25.5 | 105.8% | |
Net profit margin | % | 18.7 | 18.3 | 102.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 203,161 | 5.8% | |
Current liabilities | Rs m | 6,791 | 85,721 | 7.9% | |
Net working cap to sales | % | 40.0 | 47.6 | 84.1% | |
Current ratio | x | 1.7 | 2.4 | 72.8% | |
Inventory Days | Days | 263 | 79 | 331.7% | |
Debtors Days | Days | 343 | 107 | 320.3% | |
Net fixed assets | Rs m | 10,617 | 112,638 | 9.4% | |
Share capital | Rs m | 166 | 833 | 19.9% | |
"Free" reserves | Rs m | 7,265 | 230,571 | 3.2% | |
Net worth | Rs m | 7,431 | 231,404 | 3.2% | |
Long term debt | Rs m | 0 | 1,278 | 0.0% | |
Total assets | Rs m | 22,330 | 315,799 | 7.1% | |
Interest coverage | x | 409.1 | 43.4 | 943.5% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 70.5% | |
Return on assets | % | 10.3 | 14.7 | 70.0% | |
Return on equity | % | 30.9 | 19.5 | 158.5% | |
Return on capital | % | 42.4 | 26.6 | 159.3% | |
Exports to sales | % | 0 | 52.2 | 0.0% | |
Imports to sales | % | 13.1 | 16.8 | 77.6% | |
Exports (fob) | Rs m | NA | 128,803 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 41,484 | 3.9% | |
Fx inflow | Rs m | 1,465 | 128,803 | 1.1% | |
Fx outflow | Rs m | 1,605 | 41,484 | 3.9% | |
Net fx | Rs m | -140 | 87,319 | -0.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 58,875 | 4.0% | |
From Investments | Rs m | -215 | -41,373 | 0.5% | |
From Financial Activity | Rs m | -985 | -26,861 | 3.7% | |
Net Cashflow | Rs m | 1,160 | -9,073 | -12.8% |
Indian Promoters | % | 0.0 | 26.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 47.4 | 42.1% | |
FIIs | % | 6.2 | 29.1 | 21.4% | |
ADR/GDR | % | 0.0 | 15.4 | - | |
Free float | % | 48.2 | 58.0 | 83.1% | |
Shareholders | 56,778 | 255,500 | 22.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES SUPRIYA LIFESCIENCE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Dr. Reddys | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.18% | 4.47% | 0.97% |
1-Month | -0.72% | 1.47% | 2.08% |
1-Year | -0.85% | 28.54% | 55.37% |
3-Year CAGR | -8.62% | 7.04% | 15.04% |
5-Year CAGR | 5.02% | 16.28% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Dr. Reddys share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Dr. Reddys.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Dr. Reddys.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.